002393.SZ
002393.SZ
CNE100000NJ9
LISHENGPHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.392.014.298 1.336.154.450
4.2%
Cost of Revenue 622.787.320 600.362.548
3.7%
Gross Profit 769.226.979 735.791.902
4.5%
656.649.652 645.642.412
1.7%
Operating Income 112.577.326 90.149.490
24.9%
Pretax Income 455.605.152 215.948.800
111.0%
Net Income Common Stockholders 416.283.339 184.528.446
125.6%
-- --
--
-- --
--
ende